Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Infect Control Hosp Epidemiol ; 40(3): 368-371, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30767830

RESUMEN

We describe the high burden of carbapenemase-producing Enterobacteriaceae (CPE) colonization and infection in a neuro-rehabilitation hospital in Italy over a 6-year period. Overall, 9.3% of patients were found to be CPE carriers on admission; the rates of CPE in-hospital acquisition and CPE-BSI were 9.2 and 2.9 cases per 10,000 patient days, respectively.


Asunto(s)
Portador Sano/transmisión , Infecciones por Enterobacteriaceae/transmisión , Adulto , Enterobacteriaceae Resistentes a los Carbapenémicos , Femenino , Humanos , Incidencia , Control de Infecciones/estadística & datos numéricos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Estudios Prospectivos
2.
Infect Control Hosp Epidemiol ; 38(1): 76-82, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27745559

RESUMEN

OBJECTIVE To assess the impact of an antimicrobial stewardship program (ASP) on antibiotic consumption, Clostridium difficile infections (CDI), and antimicrobial resistance patterns in a rehabilitation hospital. DESIGN Quasi-experimental study of the periods before (from January 2011 to June 2012) and after (from July 2012 to December 2014) ASP implementation. SETTING 150-bed rehabilitation hospital dedicated to patients with spinal-cord injuries. INTERVENTION Beginning in July 2012, an ASP was implemented based on systematic bedside infectious disease (ID) consultation and structural interventions (ie, revision of protocols for antibiotic prophylaxis and education focused on the appropriateness of antibiotic prescriptions). Antibiotic consumption, occurrence of CDI, and antimicrobial resistance patterns of selected microorganisms were compared between periods before and after the ASP implementation. RESULTS Antibiotic consumption decreased from 42 to 22 defined daily dose (DDD) per 100 patient days (P<.001). The main reductions involved carbapenems (from 13 to 0.4 DDD per 100 patient days; P=.01) and fluoroquinolones (from 11.8 to 0.99 DDD per 100 patient days; P=.006), with no increases in mortality or length of stay. The incidence of CDI decreased from 3.6 to 1.2 cases per 10,000 patient days (P=.001). Between 2011 and 2014, the prevalence of extensively drug-resistant (XDR) strains decreased from 55% to 12% in P. aeruginosa (P<.001) and from 96% to 73% in A. baumannii (P=.03). The prevalence of ESBL-producing strains decreased from 42% to 17% in E. coli (P=.0007) and from 62% to 15% in P. mirabilis (P=.0001). In K. pneumoniae, the prevalence of carbapenem-resistant strains decreased from 42% to 17% (P=.005), and the prevalence of in methicillin-resistant S. aureus strains decreased from 77% to 40% (P<.0008). CONCLUSIONS An ASP based on ID consultation was effective in reducing antibiotic consumption without affecting patient outcomes and in improving antimicrobial resistance patterns in a rehabilitation hospital. Infect Control Hosp Epidemiol. 2016;1-7.


Asunto(s)
Profilaxis Antibiótica , Programas de Optimización del Uso de los Antimicrobianos/métodos , Infección Hospitalaria/prevención & control , Infecciones por Bacterias Gramnegativas/epidemiología , Infecciones por Bacterias Gramnegativas/prevención & control , Centros de Rehabilitación/organización & administración , Antibacterianos/administración & dosificación , Carbapenémicos/administración & dosificación , Fluoroquinolonas/administración & dosificación , Mortalidad Hospitalaria/tendencias , Humanos , Italia , Derivación y Consulta , Traumatismos Vertebrales/rehabilitación
3.
APMIS ; 124(6): 516-21, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27004836

RESUMEN

Enterobacter aerogenes has recently emerged as an important hospital pathogen. In this study, we showed the emergence of E. aerogenes isolates carrying the blaKPC gene in patients colonized by carbapenem-resistant Klebsiella pneumoniae strains. Two multiresistant E. aerogenes isolates were recovered from bronchial aspirates of two patients hospitalized in the Intensive Care Unit at the "Santa Maria della Scaletta" Hospital, Imola. The antimicrobial susceptibility test showed the high resistance to carbapenems and double-disk synergy test confirmed the phenotype of KPC and AmpC production. Other investigation revealed that ESBL and blaKPC genes were carried on the conjugative pKpQIL plasmid. This is a relevant report in Italy that describes a nosocomial infection due to the production of KPC beta-lactamases by an E. aerogenes isolate in patients previously colonized by K. pneumoniae carbapenem-resistant. In conclusion, it's necessary a continuous monitoring of multidrug-resistant strains for the detection of any KPC-producing bacteria that could expand the circulation of carbapenem-resistant pathogens.


Asunto(s)
Proteínas Bacterianas/genética , Infección Hospitalaria/microbiología , Enterobacter aerogenes/enzimología , Enterobacter aerogenes/aislamiento & purificación , Infecciones por Enterobacteriaceae/microbiología , Unidades de Cuidados Intensivos , beta-Lactamasas/genética , Antibacterianos/farmacología , Bronquios/microbiología , ADN Bacteriano/química , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple , Enterobacter aerogenes/efectos de los fármacos , Enterobacter aerogenes/genética , Hospitales , Humanos , Italia , Klebsiella pneumoniae/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Plásmidos/análisis , Análisis de Secuencia de ADN
4.
New Microbiol ; 38(4): 589-92, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26485019

RESUMEN

Invasive Group A Streptococcus disease is a severe and sometimes life-threatening infection with only few cases reported in literature. We describe the case of a 49-day-old male infant with invasive Group A Streptococcus infection characterized by acute otitis media and development of septicemia within a probably community-acquired cluster. The causative agent resulted to be a rare emm-89 genotype of Streptococcus pyogenes. Group A Streptococcus must be considered responsible for sepsis in newborns and young infants.


Asunto(s)
Infecciones Comunitarias Adquiridas/microbiología , Sepsis/microbiología , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/aislamiento & purificación , Genotipo , Humanos , Lactante , Masculino , Streptococcus pyogenes/genética
5.
Indian J Microbiol ; 55(3): 345-8, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26063946

RESUMEN

Chlamydophila pneumoniae is a pathogenic agent, involved in various types of infection. This study has evaluated the ability of IgG antibodies in outpatient, with acute respiratory tract infections from C. pneumoniae, to neutralize in vitro purified elementary bodies of this bacterium, revealing a good neutralizing performance of IgG antibodies.

7.
Indian J Pathol Microbiol ; 58(1): 45-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25673591

RESUMEN

BACKGROUND: Group B Streptococcus (GBS) is an important pathogen that causes serious infections in newborns. Pregnant screening and intrapartum antibiotic prophylaxis are actually the strategies to prevent GBS disease in neonates because vaccination is under investigation. MATERIALS AND METHODS: Simultaneously, 156 isolates of GBS and 156 isolates other than GBS covering 17 different species, were tested to evaluate the selectivity of a new chromogenic medium to screen GBS. RESULTS: The new new chromogenic medium showed an excellent performance, exhibiting a very high level of inclusivity (100%) and exclusivity (96.1%).


Asunto(s)
Técnicas Bacteriológicas/métodos , Medios de Cultivo/química , Infecciones Estreptocócicas/diagnóstico , Streptococcus agalactiae/aislamiento & purificación , Compuestos Cromogénicos/metabolismo , Femenino , Humanos , Lactante , Recién Nacido , Embarazo , Infecciones Estreptocócicas/microbiología
8.
APMIS ; 122(6): 552-5, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24106832

RESUMEN

Ureaplasma urealyticum is an opportunistic pathogen during pregnancy and in newborns. Other clinical problems related to U. urealyticum infections are: no susceptibility to cell wall-active drugs, limits of antibiotic treatment in pregnancy, and spread of antimicrobial resistance. In addition, the results of antimicrobial susceptibility against U. urealyticum from various countries are few and controversial. The antimicrobial susceptibility of U. urealyticum, isolated from cervical swabs and collected from outpatient childbearing-aged women in Italy from 2009 to 2012, was performed against fluoroquinolones, macrolides, streptogramin and tetracyclines, using an available biochemical commercial kit and a specific solid culture medium, to improve the therapeutic management of these pathogenic agents. Ureaplasma urealyticum was detected in 49.4% of samples, but significant bacterial load was revealed in 29.8%. In vitro tetracyclines showed the best activity against U. urealyticum, followed by streptogramin, macrolides, and fluoroquinolones.


Asunto(s)
Infecciones por Ureaplasma/tratamiento farmacológico , Infecciones por Ureaplasma/microbiología , Ureaplasma urealyticum/efectos de los fármacos , Ureaplasma urealyticum/aislamiento & purificación , Cervicitis Uterina/tratamiento farmacológico , Cervicitis Uterina/microbiología , Adolescente , Adulto , Antibacterianos/farmacología , Carga Bacteriana , Cuello del Útero/microbiología , Femenino , Humanos , Recién Nacido , Italia , Pruebas de Sensibilidad Microbiana , Infecciones Oportunistas/complicaciones , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/microbiología , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/microbiología , Tetraciclinas/farmacología , Infecciones por Ureaplasma/complicaciones , Ureaplasma urealyticum/patogenicidad , Cervicitis Uterina/complicaciones , Adulto Joven
9.
Indian J Pathol Microbiol ; 54(4): 786-9, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22234111

RESUMEN

BACKGROUND: Toxoplasma gondii infection, common parasitic zoonoses, is an important cause of spontaneous abortion, mental retardation, encephalitis, ocular disease and death worldwide. Today the major diagnostic techniques for the toxoplasmosis are serological assays, but its have many limitations. AIM: The goal in this study is to improve the diagnostic accuracy of T. gondii infection, using direct (Real Time PCR) and indirect (IgM, IgA, IgG and IgG avidity) diagnostic techniques. MATERIALS AND METHODS: In the period between 2007 and 2008, 96 non consecutive different clinical samples (38 blood, 40 amniotic fluids, 8 cerebrospinal fluids, 10 vitreous humors) and 96 sera have been studied simultaneously through molecular biology and serological techniques. RESULTS: Direct and indirect diagnostic techniques used in this study for laboratory diagnosis of T. gondii infection were always concordant. CONCLUSIONS: The high correlation between direct and indirect diagnostic techniques exhibit that serologic techniques are accurate diagnostic assays as screening test in laboratory diagnosis of toxoplasmosis.


Asunto(s)
Técnicas de Laboratorio Clínico/métodos , Toxoplasma/genética , Toxoplasma/inmunología , Toxoplasmosis/diagnóstico , Anticuerpos Antiprotozoarios/sangre , Afinidad de Anticuerpos , Femenino , Humanos , Inmunoensayo/métodos , Técnicas de Diagnóstico Molecular/métodos , Embarazo , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos
10.
Vet Microbiol ; 123(1-3): 269-73, 2007 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-17391870

RESUMEN

Nine Chlamydia suis isolates, obtained from pigs with conjunctivitis, were molecularly characterized by ompA sequencing and their in vitro susceptibility to six cathelicidin peptides (SMAP-29, BAC-7, BMAP-27, BMAP-27, BMAP-28, PG-1, LL-37) determined in cell culture. SMAP-29 was the most active peptide, reducing the intracellular inclusion number by > or =50% at a concentration of 10 microg/ml (3 microM) in six of the nine isolates tested. Three molecularly identical isolates were insensitive at a concentration as high as 80 microg/ml (25 microM). Of the remaining cathelicidin peptides tested, BAC-7 and BMAP-27 were active against six C. suis isolates at a concentration of 80 microg/ml (25 and 26 microM, respectively). Cathelicidins LL-37 and PG-1 did not show any anti-chlamydial activity at 80 microg/ml.


Asunto(s)
Antibacterianos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Chlamydia/clasificación , Chlamydia/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Antibacterianos/química , Péptidos Catiónicos Antimicrobianos/química , Catelicidinas , Bovinos , Línea Celular , Chlorocebus aethiops , Humanos , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA